Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Research output: Contribution to journalLetterResearchpeer-review

  • Jakob Schöllhammer Knudsen
  • Reimar Wernich Thomsen
  • Anton Pottegård
  • Knop, Filip Krag
  • Henrik Toft Sørensen
Original languageEnglish
JournalDiabetes Care
Volume41
Issue number9
Pages (from-to)e133-e135
Number of pages3
ISSN0149-5992
DOIs
Publication statusPublished - 2018

ID: 216460411